QA: NORTHWEST BIOTHERAPEUTICS INC in us_pharma/2019

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001072379_2020_NORTHWEST_BIOTHERAPEUTICS_INC.pdf

Logs

warning Missing logo subcommand.report {}
info Minor missing amount for aggregate added to remainder industry.us_generic {'aggregate': 'Assets', 'missing_ratio': 0.043314285714285715, 'aggregate_val': 9129000, 'exp_sum': 8750000, 'exp_to_value': {'AssetsCurrent': 3200000, 'IntangibleAssetsNetIncludingGoodwill': 0, 'PropertyPlantAndEquipmentNet': 281000, 'remainder_Assets': 5269000}}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001072379')"}
info Ambiguous roles for statement input.sec.calculation_linkbase.expand_agg {'statement': 'operations', 'valid_roles': {'00200 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - Calc 2': 2, '00200 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS': 15}}
info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0001072379, NORTHWEST BIOTHERAPEUTICS INC

  xvar xval
0 AssetsCurrent 3,200,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 281,000
3 remainder_Assets 5,648,000
4 LiabilitiesCurrent 41,194,000
5 LiabilitiesNoncurrent 11,502,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 12,541,000
9 ResearchAndDevelopmentExpense 13,590,000
10 remainder_Expenses 3,742,000
11 remainder_Revenues 2,410,000
12 remainder_NetIncome 7,167,000
13 remainder_ComprehensiveNetIncome -164,000
  yvar yval
0 Assets 9,129,000
1 Liabilities 52,696,000
2 Expenses 29,873,000
3 Revenues 2,410,000
4 StockholdersEquity -43,567,000
5 NetIncome -20,296,000
6 ComprehensiveNetIncome -20,378,000
7 BaseVar 50,719,500
8 EconomicCapitalRatio -3.08

Edgar->Model Mapping

Feature Distribution

Change over Time